Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice

Arthritis Care and Research

Volumn 63, Issue 9, 2011, Pages 1247-1253

  Fukae, Jun ^a   Isobe, Masato ^a   Kitano, Akemi ^a   Henmi, Mihoko ^a   Sakamoto, Fumihiko ^a   Narita, Akihiro ^a   Ito, Takeya ^a   Mitsuzaki, Akio ^a   Shimizu, Masato ^a   Tanimura, Kazuhide ^a   Matsuhashi, Megumi ^a   Kamishima, Tamotsu ^b   Atsumi, Tatsuya ^c   Koike, Takao ^c  

^a HOKKAIDO MEDICAL CENTER   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; TOCILIZUMAB;

ADULT; AGED; ARTICLE; BONE RADIOGRAPHY; CLINICAL ARTICLE; CLINICAL PRACTICE; DISEASE ACTIVITY; DOPPLER ECHOGRAPHY; FEMALE; FINGER INJURY; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HUMAN; INTERPHALANGEAL JOINT; MALE; METACARPOPHALANGEAL JOINT; PREDICTIVE VALUE; PROGNOSIS; RHEUMATOID ARTHRITIS; SYNOVIAL VASCULARIZATION; SYNOVIUM; VASCULARIZATION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; FINGER JOINT; HUMANS; JAPAN; MALE; METACARPOPHALANGEAL JOINT; MIDDLE AGED; OBSERVER VARIATION; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, PULSED;

EID: 80052278676     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20517     Document Type: Article

References (25)

1. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727-35.
2. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL,. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
3. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008; 58: 2958-67.
4. Koch AE,. Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 1998; 41: 951-62. (Pubitemid 28265398)
5. Newman JS, Adler RS, Bude RO, Rubin JM,. Detection of soft-tissue hyperemia: value of power Doppler sonography. AJR Am J Roentgenol 1994; 163: 385-9. (Pubitemid 24242526)
6. Naredo E, Moller I, Cruz A, Carmona L, Garrido J,. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum 2008; 58: 2248-56.
7. Naredo E, Collado P, Cruz A, Palop MJ, Cabero F, Richi P, et al. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. Arthritis Rheum 2007; 57: 116-24.
8. Peluso G, Michelutti A, Bosello S, Gremese E, Tolusso B, Ferraccioli G,. Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. Ann Rheum Dis 2011; 70: 172-5.
9. Magni-Manzoni S, Epis O, Ravelli A, Klersy C, Visconti C, Lanni S, et al. Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis. Arthritis Rheum 2009; 61: 1497-504.
10. Fukae J, Kon Y, Henmi M, Sakamoto F, Narita A, Shimizu M, et al. Change of synovial vascularity in a single finger joint assessed by power Doppler sonography correlated with radiographic change in rheumatoid arthritis: comparative study of a novel quantitative score with a semiquantitative score. Arthritis Care Res (Hoboken) 2010; 62: 657-63.
11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24. (Pubitemid 18091653)
12. Kamishima T, Tanimura K, Henmi M, Narita A, Sakamoto F, Terae S, et al. Power Doppler ultrasound of rheumatoid synovitis: quantification of vascular signal and analysis of interobserver variability. Skeletal Radiol 2009; 38: 467-72.
13. Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA, et al. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 2001; 60: 641-9. (Pubitemid 32588366)
14. Genant HK, Jiang Y, Peterfy C, Lu Y, Redei J, Countryman PJ,. Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum 1998; 41: 1583-90. (Pubitemid 28459916)
15. Bruynesteyn K, Boers M, Kostense P, van der Linden S, van der Heijde D,. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis 2005; 64: 179-82. (Pubitemid 40193607)
16. Karonitsch T, Aletaha D, Boers M, Bombardieri S, Combe B, Dougados M, et al. Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis. Ann Rheum Dis 2008; 67: 1365-73.
17. Sokka T, Pincus T,. Rheumatoid arthritis: strategy more important than agent. Lancet 2009; 374: 430-2.
18. Hoff M, Kvien TK, Kalvesten J, Elden A, Haugeberg G,. Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study. Ann Rheum Dis 2009; 68: 1171-6.
19. Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 2004; 50: 1761-9. (Pubitemid 38725087)
20. Nishimoto N, Hashimoto J, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis 2007; 66: 1162-7. (Pubitemid 47309731)
21. Hashimoto J, Garnero P, van der Heijde D, Miyasaka N, Yamamoto K, Kawai S, et al. Humanized anti-interleukin- 6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study. Mod Rheumatol 2011; 21: 10-5.
22. Moller Dohn U, Boonen A, Hetland ML, Hansen MS, Knudsen LS, Hansen A, et al. Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab: a 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure. Ann Rheum Dis 2009; 68: 1585-90.
23. Dohn UM, Ejbjerg B, Boonen A, Hetland ML, Hansen MS, Knudsen LS, et al. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study. Ann Rheum Dis 2011; 70: 252-8.
24. Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006; 54: 3761-73. (Pubitemid 44955876)
25. Smolen JS, Boers M, Abadie EC, Breedveld FC, Emery P, Bardin T, et al. Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA. Curr Med Res Opin 2011; 27: 315-25.